EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Little Green Pharma's enterprise value is A$38.80 Mil.
Little Green Pharma's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was A$-1.78 Mil. Therefore, Little Green Pharma's EV-to-EBITDA for today is -21.82.
The historical rank and industry rank for Little Green Pharma's EV-to-EBITDA or its related term are showing as below:
ASX:LGP'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -21.83 Med: -4.58 Max: 4.45
Current: -21.83
During the past 4 years, the highest EV-to-EBITDA of Little Green Pharma was 4.45. The lowest was -21.83. And the median was -4.58.
ASX:LGP's EV-to-EBITDA is ranked worse than 100% of 708
companies
in the Drug Manufacturers industry
Industry Median: 14.22
vs ASX:LGP: -21.83
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Little Green Pharma EV-to-EBITDA Historical Data
The historical data trend for Little Green Pharma's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Little Green Pharma's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's EV-to-EBITDA falls into.
Little Green Pharma's current Enterprise Value is A$38.80 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was A$-1.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Little Green Pharma's PE Ratio for today is calculated as:
Little Green Pharma's share price for today is A$0.13.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was A$-0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Little Green Pharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Little Green Pharma (ASX:LGP) Business Description
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:LGP has been successfully added to your